<産業資料/調査レポートの題名> 2022年4月19日

In situハイブリダイゼーション(ISH)の世界市場2020-2024


◆英文タイトル:Global In Situ Hybridization (ISH) Market 2020-2024

01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
1. 2.1 Preface
2. 2.2 Preface
2.3 Currency conversion rates for US$
03: MARKET LANDSCAPE
3. Market ecosystem
4. Market characteristics
5. Market segmentation analysis
04: MARKET SIZING
6. Market definition
7. Market sizing 2019
8. Market size and forecast 2019-2024
05: FIVE FORCES ANALYSIS
9. Bargaining power of buyers
10. Bargaining power of suppliers
11. Threat of new entrants
12. Threat of substitutes
13. Threat of rivalry
14. Market condition
06: MARKET SEGMENTATION BY TECHNOLOGY
15. Market segmentation by technology
16. Comparison by technology
17. FISH – Market size and forecast 2019-2024
18. CISH – Market size and forecast 2019-2024
19. Market opportunity by technology
07: CUSTOMER LANDSCAPE
08: MARKET SEGMENTATION BY END-USER
20. Market segmentation by end-user
21. Comparison by end-user
22. Molecular diagnostic laboratories – Market size and forecast 2019-2024
23. Pharmaceutical and biotechnology companies –
24. Market size and forecast 2019-2024
25. Others – Market size and forecast 2019-2024
26. Market opportunity by end-user
09: GEOGRAPHIC LANDSCAPE
27. Geographic segmentation
28. Geographic comparison
29. North America – Market size and forecast 2019-2024
30. Europe – Market size and forecast 2019-2024
31. APAC – Market size and forecast 2019-2024
32. South America – Market size and forecast 2019-2024
33. MEA – Market size and forecast 2019-2024
34. Key leading countries
35. Market opportunity
10: DECISION FRAMEWORK
11: DRIVERS AND CHALLENGES
36. Market drivers
37. Market challenges
12: MARKET TRENDS
38. Increasing M&A activity in molecular diagnostics market
39. National initiatives across the globe spurring molecular research activities
40. Increasing importance of promotional activities
13: VENDOR LANDSCAPE
41. Overview
42. Landscape disruption
43. Competitive scenario
14: VENDOR ANALYSIS
44. Vendors covered
45. Vendor classification
46. Market positioning of vendors
47. Abbott Laboratories
48. Agilent Technologies Inc.
49. Bio-Rad Laboratories Inc.
50. Bio-Techne Corp.
51. F. Hoffmann-La Roche Ltd.
52. Merck KGaA
53. NeoGenomics Inc.
54. PerkinElmer Inc.
55. Qiagen NV
56. Thermo Fisher Scientific Inc.
15: APPENDIX
57. Research methodology
58. List of abbreviations
59. Definition of market positioning of vendors
16: EXPLORE TECHNAVIO


Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Differences between CISH and FISH
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Technology – Market share 2019-2024 (%)
Exhibit 19: Comparison by technology
Exhibit 20: FISH – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: FISH – Year-over-year growth 2020-2024 (%)
Exhibit 22: CISH – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: CISH – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by technology
Exhibit 25: Customer landscape
Exhibit 26: End-user – Market share 2019-2024 (%)
Exhibit 27: Comparison by end-user
Exhibit 28: Molecular diagnostic laboratories – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: Molecular diagnostic laboratories – Year-over-year growth 2020-2024 (%)
Exhibit 30: Pharmaceutical and biotechnology companies – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Pharmaceutical and biotechnology companies – Year-over-year growth 2020-2024 (%)
Exhibit 32: Others – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Others – Year-over-year growth 2020-2024 (%)
Exhibit 34: Market opportunity by end-user
Exhibit 35: Market share by geography 2019-2024 (%)
Exhibit 36: Geographic comparison
Exhibit 37: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 38: North America – Year-over-year growth 2020-2024 (%)
Exhibit 39: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 40: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 41: APAC – Market size and forecast 2019-2024 ($ millions)
Exhibit 42: APAC – Year-over-year growth 2020-2024 (%)
Exhibit 43: South America – Market size and forecast 2019-2024 ($ millions)
Exhibit 44: South America – Year-over-year growth 2020-2024 (%)
Exhibit 45: MEA – Market size and forecast 2019-2024 ($ millions)
Exhibit 46: MEA – Year-over-year growth 2020-2024 (%)
Exhibit 47: Key leading countries
Exhibit 48: Market opportunity
Exhibit 49: List of FDA-approved companion diagnostic tests using ISH
Exhibit 50: Head-to-head comparison between traditional FISH and DMI
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Vendor landscape
Exhibit 53: Landscape disruption
Exhibit 54: Vendors covered
Exhibit 55: Vendor classification
Exhibit 56: Market positioning of vendors
Exhibit 57: Abbott Laboratories – Vendor overview
Exhibit 58: Abbott Laboratories – Business segments
Exhibit 59: Abbott Laboratories – Organizational developments
Exhibit 60: Abbott Laboratories – Geographic focus
Exhibit 61: Abbott Laboratories – Segment focus
Exhibit 62: Abbott Laboratories – Key offerings
Exhibit 63: Agilent Technologies Inc. – Vendor overview
Exhibit 64: Agilent Technologies Inc. – Business segments
Exhibit 65: Agilent Technologies Inc. – Organizational developments
Exhibit 66: Agilent Technologies Inc. – Geographic focus
Exhibit 67: Agilent Technologies Inc. – Segment focus
Exhibit 68: Agilent Technologies Inc. – Key offerings
Exhibit 69: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 70: Bio-Rad Laboratories Inc. – Business segments
Exhibit 71: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 72: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 73: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 74: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 75: Bio-Techne Corp. – Vendor overview
Exhibit 76: Bio-Techne Corp. – Business segments
Exhibit 77: Bio-Techne Corp. – Organizational developments
Exhibit 78: Bio-Techne Corp. – Geographic focus
Exhibit 79: Bio-Techne Corp. – Segment focus
Exhibit 80: Bio-Techne Corp. – Key offerings
Exhibit 81: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 82: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 83: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 84: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 85: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 86: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 87: Merck KGaA – Vendor overview
Exhibit 88: Merck KGaA – Business segments
Exhibit 89: Merck KGaA – Organizational developments
Exhibit 90: Merck KGaA – Geographic focus
Exhibit 91: Merck KGaA – Segment focus
Exhibit 92: Merck KGaA – Key offerings
Exhibit 93: NeoGenomics Inc. – Vendor overview
Exhibit 94: NeoGenomics Inc. – Business segments
Exhibit 95: NeoGenomics Inc. – Organizational developments
Exhibit 96: NeoGenomics Inc. – Segment focus
Exhibit 97: NeoGenomics Inc. – Key offerings
Exhibit 98: PerkinElmer Inc. – Vendor overview
Exhibit 99: PerkinElmer Inc. – Business segments
Exhibit 100: PerkinElmer Inc. – Organizational developments
Exhibit 101: PerkinElmer Inc. – Geographic focus
Exhibit 102: PerkinElmer Inc. – Segment focus
Exhibit 103: PerkinElmer Inc. – Key offerings
Exhibit 104: Qiagen NV – Vendor overview
Exhibit 105: Qiagen NV – Business segments
Exhibit 106: Qiagen NV – Organizational developments
Exhibit 107: Qiagen NV – Geographic focus
Exhibit 108: Qiagen NV – Segment focus
Exhibit 109: Qiagen NV – Key offerings
Exhibit 110: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 111: Thermo Fisher Scientific Inc. – Business segments
Exhibit 112: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 113: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 114: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 115: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 116: Validation techniques employed for market sizing
Exhibit 117: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark